Moreover, studies have shown that HMG-CoA reductase inhibitors (drugs that significantly inhibit cholesterol and, subsequently, bile acid synthesis) reduce mortality in sepsis and infection-related ARDS [46–48]. The gene discussed is HMGCR; the disease is Sepsis.